RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS

Similar documents
Pogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International Advisory Board

NORDIC CONFERENCE ON RARE DISEASES

STRATEGIC APPROACH & WORKPLAN 2007

Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

rare diseases research through National Plans and Strategies

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective

The basics a. Mission Statement (unchanged) eurordi s.org

The EU rare diseases policy framework: the context for ERNs

Update from IMI PREFER: Patient preferences in benefitrisk assessments during the medical product lifecycle

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report

Summary Report EU Health Award 2017

Table Of Content. Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners...

the patients perspective and role of epags

A multi-stakeholder partnership initiative. 10 February 2012

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report

Political advocacy: a way to achieve better outcomes for people with Parkinson s disease and their families A workshop on engaging effectively with

The Life Course Immunisation Initiative

Maltese Presidency of the Council of the European Union. Ministry for Health

Workshop on Extrapolation and Evidence Synthesis in the Development and Therapeutic Use of Medicines in Children

Rare Cancer Perspective in the EUCERD

Results Based Advocacy to Increase Access Marie Stopes International

ACTION PLAN Adoption Annual Activity & Financial Report 2018 Adoption Work Programme: Action Plan & Budget 2019

Table Of Content. EURORDIS_FY Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7

State of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report

INAHTA Workshop: How to Set up an HTA Agency

An introduction to the Alliance for Maternal Health Equality

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Obesity Policy in the EU - evaluating the options. Cross-national findings

European Patients Academy on Therapeutic Innovation

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

Introducing NCCN Academy for Excellence & Leadership in Oncology April Program Overview

What EU research policy can do for conditions such as chronic pain?

STRATEGIC PLAN

DRAFT STRATEGIC APPROACH & ACTION PLAN For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

European map of investments in innovative digital solutions for AHA Early results

RARE-Bestpractices Project. Final Conference

Peer counselling A new element in the ET2020 toolbox

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report

EFSA s Reputation Barometer

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014

EuroHealthNet. EU Compass for Action on Mental health & Well-being. EUREGHA seminar: Mental Health in the Young 27 April 2017

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

B.I.R.O. Best Information through Regional Outcomes

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

Consultation Strategy. Impact Assessment on an initiative to limit industrial trans fats intakes in the EU

ILC Singapore Report. ILC Singapore

Healthy Workplaces for All Ages Promoting a sustainable working life

Counting down to zero

Secondary Prevention Alliance. Progress and Achievements Report. August 2014

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer

Joint Programming in Neurodegenerative Disease Research (JPND)

Changing the prevention paradigm for the future what Europe can do

2016 NYC Hep B Coalition Work Plan

DRAFT STRATEGIC APPROACH & ACTION PLAN For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016

ALCOHOL, TOBACCO & OTHER DRUGS COUNCIL TAS INC.

PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH

INSIGHTS INTO ADHD CARE IN GERMANY BASED ON SHI CLAIMS DATA 03. March Results of the CoCA Study (Horizon 2020)

MHE Position on the EC Green Paper on Mental Health An EU Strategy on Mental Health and Well Being

Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner

Engaging to Improve Access Zack Pemberton-Whiteley. Head of Campaigns and Advocacy Leukaemia CARE, UK

European Dietetic Action Plan EuDAP ( )

Transforming health through IT

Sponsorship Prospectus

2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

Highlights from the SUN Civil Society Network Annual Survey 2017 Img.1 SUNCSN Learning Route in Rwanda, Gisagara District

Health and Social Care Alliance Scotland: People at the Centre

LIST OF RARE CANCERS AND ITS RATIONALE

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France)

You said, We did. How your comments and feedback have helped us to add value and improve local services

Outcomes of the Nutri-Senex Project: A Co-Ordination Action Funded by the European Commission

7 th European Conference on Rare Diseases & Orphan Products (ECRD 2014 Berlin) The Rare Disease Puzzle: Bringing the Picture to Life

Successful collaboration for research development between the NIH and patient organisations

The European Brain Council

Exercise & Sports Science Australia Submission: global action plan to promote physical activity

April 2019 NATIONAL POLICY PLATFORM

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Self-regulatory proposal from the european alcoholic beverages sectors on the provision of nutrition information and ingredients listing

Commonwealth Secretariat

SPOTLIGHT for policy-making

The Global Network Aiming to deliver safe quality care in relation to tobacco for every service user, every time and everywhere

IOF TOOLKIT IOF COMPENDIUM OF OSTEOPOROSIS. Our vision is a world without fragility fractures, in which healthy mobility is a reality for all.

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable)

TABLE of Contents. EURORDIS in brief

Society for Industrial and Organizational Psychology 2006 Member Survey Overall Report. Prepared by

Alcohol Research UK Research Strategy

Retina International General Assembly Auckland, New Zealand

A European Quality Assurance Scheme for Breast Cancer Services - updates Joint Research Centre

Pfizer Support to European and International Patient Organisations in 2008

Table Of Content. European network to reduce vulnerabilities in health... 2 Summary... 3 Work Package... 10

International Bureau for Epilepsy MEMBERSHIP GUIDE Benefits and Responsibilities

ECIBC overview. Donata LERDA Healthcare Quality Team leader

Health literacy interventions at the service delivery/institutional level: country examples

Transcription:

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS Stakeholder Group Interest in RD-Action Dissemination purpose Channels of Dissemination (WHO) (WHY) (WHY) (HOW) Partners of RD-Action & members of the CEG-RD - Orphanet (central & national offices) - Patient Organisations - Academia - Member States To integrate progress and information into their own work. Seek opportunities to input and influence decision making. Receive support on policy methodology. Production of data to support policy analyses and decisions. Inform: Update on progress of project. Engage: back and forth exchange of information. Promote: To further disseminate updates within their networks. Orphanet, all partners website. Newsletters: DG SANTE, OrphaNews, RD- Action internal newsletter; all partners newsletter. Posters. 1 P a g e

Joint Action s meetings & conference calls. RD-ACTION Final Report. National and local competent authorities - Health ministries - Research ministries - Social affairs ministries - Regional level health competency authorities and their platforms - Health institutes - Local social service providers Production of data to support policy analysis and decision. To facilitate integration of EU policy into national and local policies. Support from national workshops. Quantify the burden and the resources for sustainable and resilient health systems. Inform: Update on new data, guidelines and latest information on RD policy development. Update of RD classification. Engage: Share experiences of integrating RD policy in individual MS. Support the organisation of the national workshops. Promote: To take EUCERD/ CEG-RD Recommendations on board and to implement within MS. Guidelines and review paper on how and why using Orphacode. Orphanet, other partners website. Newsletters: DG SANTE, OrphaNews, RD- Action internal newsletter; other partners newsletter. 2 P a g e

Regulators Clearer regulatory conditions when RD is better defined. Obtaining information on relevant policy developments. Orphanet, other partners website. Newsletters: DG SANTE, OrphaNews, other partners newsletter. Reports of conferences and workshops HTA bodies/reimbursement authorities Improved codification means easier to identify and track diseases through the reimbursement process. Websites: Orphanet Newsletters: OrphaNews. Reports of conferences and workshops EU decision-makers - European Commission: DG SANTE (in particular Public Health and Health Systems and Products), DG CONECT, DG EMPL, DG RTD, CHAFEA - European Parliament: MEPs, Information about national RD initiatives. Recommendations to help drive European policy. Production of data to support policy analysis and decision; and to facilitate integration of EU policies. Promote: To take the recommendations on board and to encourage them to advocate for adoption by MS. Engage: Use data and recommendations to Orphanet. 3 P a g e

ENVI and ITRE committees - Committee of Regions - Economic and Social Council Quantify the burden and the resources for sustainable and resilient health systems. facilitate integration into European policy development; Encourage an information flow. Newsletters: DG SANTE, OrphaNews. Attendance at WP6 Policy Workshops RD-ACTION Final Report. Healthcare professionals - RD specific groups - GPs - Specialised MDs - Nurses - Paramedics - Case Managers - Social Workers - Hospital Managers Improved identification and diagnosis of RD. Improved access to treatment for patients. Better and more constructive networks. classification and policy developments in the RD field. Engage: Provide input, patient data and participate in the debate. Participate in national workshops. Websites: RD-ACTION, Orphanet, other partners website. Newsletters: OrphaNews, other partners newsletter. Scientific articles. Attendance at WP6 Policy Workshops; WP2 National Workshops. Industry (Health Related Private Sector) - Pharmaceutical and Biotech companies - Medical devices companies - Trade associations - (Bio) Informatics Companies - Insurance Companies Better understanding of RD: - Unmet needs of treatment of RD. - Clearer regulatory procedures. Better codification. Information on national plans: public budget and initiatives in MS. classification and policy developments in the RD field. Promote: Policy developments. Engage: Participate in policy and national workshops. Websites: RD-ACTION, Orphanet. Newsletters: DG SANTE, OrphaNews. 4 P a g e

Better and more constructive of networks and access to Centres of Expertise. Attendance at WP6 Policy Workshops; WP2 National Workshops. Academia; researchers Clearer codification and scientific understanding of RD. Publication of procedures and data sources and updates history. Web-based knowledge management services to access and contribute to. Engage: Mobilise to curate on Orphanet database. Websites: RD-ACTION, Orphanet, other partners website. Participate in policy and national workshops. Newsletters: DG SANTE, OrphaNews, other partners newsletter. Posters. Attendance at WP6 Policy Workshops; WP2 National Workshops. Patients advocacy and support groups - EURORDIS member organisations Improve the quality of life of People Living with Rare Diseases. Inform: Delivery of information on RD and expert service in Europe through the Orphanet website. Raise awareness Participation in surveys. Websites: Orphanet, EURORDIS, other partners website. 5 P a g e

- EURORDIS National Alliances - EURORDIS European Federations - RD patient organisations non -member of EURORDIS Promote: To take part in advocacy actions, putting pressure on national authorities to continue implementation of RD policy at MS level. Newsletters: OrphaNews, EURORDIS e- news, other partners newsletter. Engage: Organisation and attendance at national workshops. Posters. Attendance at WP2 National Workshops. Patients, families and their representatives Policy and academic development Raise Awareness Inform: Educate patients and families about policy development and their impact on their daily life. Websites: RD-Action, Orphanet, EURORDIS, other partners website. Newsletters: OrphaNews, EURORDIS e- news, other partners newsletter. Beyond RD communities - Other Joint Actions and other disease areas e.g. Chronic diseases - Other policy areas e.g. ehealth - Other patient communities Insight into work and activities carried out within RD-ACTION. Data of interest. Update on cross-cutting issues. Raise awareness: Of RD and the work done in this field. Promote: Policy developments and good practices in the RD field. Engage: Encourage to share practices and consider integrating RD into their practices. Websites: DG SANTE, Orphanet, RD- ACTION. Newsletters: DG SANTE Poster. 6 P a g e